Vontobel Holding’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$285K Sell
2,690
-887
-25% -$94.1K ﹤0.01% 939
2025
Q1
$444K Sell
3,577
-656
-15% -$81.4K ﹤0.01% 822
2024
Q4
$521K Sell
4,233
-939
-18% -$116K ﹤0.01% 777
2024
Q3
$576K Sell
5,172
-1,788
-26% -$199K ﹤0.01% 751
2024
Q2
$743K Buy
6,960
+699
+11% +$74.6K ﹤0.01% 659
2024
Q1
$754K Buy
6,261
+3,014
+93% +$363K 0.01% 663
2023
Q4
$399K Sell
3,247
-291
-8% -$35.8K ﹤0.01% 852
2023
Q3
$458K Buy
3,538
+281
+9% +$36.4K ﹤0.01% 794
2023
Q2
$404K Sell
3,257
-305
-9% -$37.8K ﹤0.01% 850
2023
Q1
$521K Sell
3,562
-54
-1% -$7.9K ﹤0.01% 766
2022
Q4
$567K Sell
3,616
-593
-14% -$93.1K 0.01% 723
2022
Q3
$561K Buy
4,209
+244
+6% +$32.5K 0.01% 682
2022
Q2
$620K Sell
3,965
-265
-6% -$41.4K 0.01% 659
2022
Q1
$666K Sell
4,230
-1,082
-20% -$170K 0.01% 718
2021
Q4
$681K Buy
5,312
+148
+3% +$19K 0.01% 735
2021
Q3
$673K Buy
5,164
+3,438
+199% +$448K 0.01% 708
2021
Q2
$309K Buy
+1,726
New +$309K ﹤0.01% 908